Skip to main content

Intellectual Property

Esperovax Wins USPTO Nod for In Vivo Yeast Protein Platform

Image
Esperovax Wins USPTO Nod for In Vivo Yeast Protein Platform

Plymouth, Mich. – – September 16, 2026 -- Esperovax, Inc. has secured a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application No. 18/038,673, covering its engineered yeast platform for producing therapeutic proteins directly inside the body.

USPTO clears patent covering in vivo yeast-based protein expression

The allowed application, titled "Yeast-Based Expression of Therapeutic Proteins In Vivo," protects technology that uses engineered yeast administered to patients to manufacture biologic proteins within the body itself, rather than requiring external production and repeated dosing of purified biologics.

Tulip Launches Patent Pool With 125,000 Imaging Patents From Canon, Sony, Huawei, OPPO

Image
Tulip Launches Patent Pool With 125,000 Imaging Patents From Canon, Sony, Huawei, OPPO

London – September 15, 2026 -- Tulip Licensing Ltd has launched Tulip Imaging, a patent licensing program granting implementers access to more than 125,000 patents covering digital imaging and information processing technologies contributed by Canon Inc., Sony Group Corporation, Huawei Technologies Co., Ltd., and Guangdong OPPO Mobile Telecommunications Corp., Ltd.

Four technology giants pool 125,000-plus patents into a single licensing program

The combined portfolio spans decades of research from four of the largest imaging technology developers globally, covering optics, cameras, image processing, computational photography, and artificial intelligence-driven imaging systems. Tulip describes the offering as the most significant consolidation of digital imaging and information processing patents to date, allowing implementers to tailor licenses to specific products and business needs rather than negotiating separately with each patent holder.

Dermatologist Zirvi Honored by Marquis Who's Who as Illumina IP Case Concludes

Image
Dermatologist Zirvi Honored by Marquis Who's Who as Illumina IP Case Concludes

Uniondale, N.Y. – September 15, 2026 -- Marquis Who's Who has included Monib A. Zirvi, MD, PhD, in its biographical volumes, recognizing more than two decades of work in dermatology and diagnostic genetics as a related patent dispute involving Illumina Inc. reaches final resolution.

Zirvi Has Practiced Dermatology at Summit Health Since 2004

Dr. Zirvi has served as a dermatologist with Summit Health and as an attending physician at Atlantic Health System's Overlook Medical Center since 2004, focusing on general dermatology, skin cancer detection and hair and nail disorders. Summit Health named him among its 2026 Castle Connolly Top Doctors. He is board certified by the American Board of Dermatology and holds a courtesy instructor appointment in microbiology and immunology at Weill Cornell Medicine, where he earned his MD and PhD.

GameChange Energy Sues Nextpower Over Solar Tracker Patent

Image
GameChange Energy Sues Nextpower Over Solar Tracker Patent

Norwalk, Connecticut – September 15, 2026 -- GameChange Energy's subsidiary, GameChange Solar Corp., has filed a patent infringement lawsuit against Nextpower in the U.S. District Court for the District of Delaware, alleging unauthorized use of its high-tilt stow tracker technology.

Lawsuit targets Nextpower's tracker systems over U.S. Patent 12,449,161

The complaint states that GameChange Solar Corp. holds U.S. Patent 12,449,161, which covers the disputed high-tilt stow technology used in its single-axis solar tracker systems. GameChange contends that Nextpower's products infringe on one or more claims of this patent.

GameChange seeks injunction and monetary damages

GameChange Solar Corp. is seeking injunctive relief to halt further alleged infringement by Nextpower, along with monetary damages tied to the claim. No financial figures for damages sought were disclosed in the filing.